This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Unversität Zürich. Active years: 2021-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2023
Title: Simone Popp: Innovator in Monoclonal Antibody Research
Introduction
Simone Popp is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of immunology, particularly through his work on humanized monoclonal antibodies. With a total of 2 patents, Popp's innovations are paving the way for advancements in therapeutic applications.
Latest Patents
Popp's latest patents include "Immune-stimulating humanized monoclonal antibodies against human interleukin-2, and fusion proteins thereof." This invention focuses on antibodies that bind to human interleukin-2 (hIL-2). More specifically, it relates to humanized antibodies that target a particular epitope of hIL-2. When these antibodies bind to this epitope, they exhibit a unique capability of inhibiting the binding of hIL-2 to CD25.
Career Highlights
Simone Popp is affiliated with Universität Zürich, where he continues to advance his research in immunology. His work has garnered attention for its potential impact on therapeutic strategies for various diseases.
Collaborations
Popp collaborates with talented individuals in his field, including Natalia Arenas-Ramirez and Iwan Beuvink. These collaborations enhance the research environment and contribute to innovative solutions in antibody development.
Conclusion
Simone Popp's contributions to the field of immunology through his patents and collaborations highlight his role as a leading inventor. His work on humanized monoclonal antibodies is set to make a significant impact in therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile